The cardiovascular risk of JAK inhibitors in treating rheumatic diseases
International Journal of Rheumatic Diseases · 2024
DOI: 10.1111/1756-185x.15308 ↗Kurz gefasst
Editorial in der Zeitschrift International Journal of Rheumatic Diseases, 2024. Verfasst von Alexander Kwan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, Department of Medicine, The University of Melbourne, Western Health, Footscray Hospital, Footscray, Victoria, Australia. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Heart Disease Risk Factors, Janus Kinase Inhibitors, Rheumatic Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
traditional cardiovascular risk factors in patients with rheumatic disease. A threshold effect may exist where mainly older patients with cardiovascular risk factors or smoking history experience a higher cardiovascular risk with JAKi use. 30 Since randomized controlled studies investigating the cardiovascular risk of JAKi are time consuming and expensive, future cohort studies and post-marketing data analyses are perhaps better suited for assessing JAKi cardiovascular risk. These should stratify patients into subgroups according to cardiovascular risk, cardiometabolic parameters, and other characteristics (such as smoking history) to determine when the benefit of JAKi use is outweighed by the risk of MACE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rheumatology Unit, Department of Medicine, The University of Melbourne, Western Health, Footscray Hospital, Footscray, Victoria, Australia.
ORCID-Profile: Alexander Kwan
Zitieren
APA
Kwan, A., Ingrid, E., Jiang, M., & Lim, K. K. T. (2024). The cardiovascular risk of JAK inhibitors in treating rheumatic diseases. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.15308
Vancouver
Kwan A, Ingrid E, Jiang M, Lim KKT. The cardiovascular risk of JAK inhibitors in treating rheumatic diseases. International Journal of Rheumatic Diseases. 2024. doi:10.1111/1756-185x.15308
BibTeX
@article{Kwan2024,
author = {Kwan, Alexander and Ingrid, Elvina and Jiang, Matthew and Lim, Keith K T},
title = {The cardiovascular risk of JAK inhibitors in treating rheumatic diseases},
journal = {International Journal of Rheumatic Diseases},
year = {2024},
doi = {10.1111/1756-185x.15308}
}
EUVIMED